The bacterium H. pylori is a leading cause of stomach cancer, and Vanderbilt researchers are studying how one of its toxins gets into cells.

New research links nutrient-responsive cellular signaling to the antibody-mediated immune response.

Treatments for common skin conditions such as atopic dermatitis may be improved by understanding the enzymes responsible for forming the skin’s water-tight barrier.

Vanderbilt investigators have discovered that cancer treatment induces an “idling” state for cells, which could promote resistance to treatment.

New findings highlight microRNAs — molecules that regulate gene expression — that are differentially expressed in glaucoma and could be candidate biomarkers or targets for therapy.

Structural views of the proteins that regulate the heartbeat may help improve existing treatments for cardiac arrhythmias.

Lung diseases of infancy and aging share a molecular signature, pointing to a potential target for treatment and prevention.